| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $200.5M | +3.9% |
| Cost of Revenue | $89.3M | +6.9% |
| Gross Profit | $111.1M | +1.5% |
| R&D Expense | $39.4M | -10.8% |
| SG&A Expense | $43.1M | -2.0% |
| Operating Income | -$20.5M | +26.3% |
| Pre-tax Income | -$5.7M | +63.7% |
| Income Tax | $320K | +109.0% |
| Net Income | -$6.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.7M | -41.0% |
| Accounts Receivable | $60.6M | +8.3% |
| Inventory | $43.9M | -27.9% |
| Current Assets | $396.4M | +1.1% |
| Total Assets | $499.5M | +1.0% |
| Current Liabilities | $67.7M | +20.3% |
| Total Liabilities | $103.8M | +2.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.4M | +380.6% |
| Capital Expenditures | $3.5M | -24.2% |
| Investing Cash Flow | -$83.0M | +11.6% |
| Financing Cash Flow | -$15.8M | +62.2% |
| Free Cash Flow | $21.9M | +3352.4% |
| +50.4% |
| Stockholders' Equity |
| $395.7M |
| +0.7% |